1. Bielack, S., Kempf-Bielack, B., Schwenzer, D., Birkfellner, T., Delling, G., Ewerbeck, V., Exner, GU., Fuchs, N., Gobel, U., Graf, N., Heise, U., Helmke, K., Hochstetter, AR., Jurgens, H., Maas, R., Munchow, N., Salzer-Kuntschik, M., Treuner, J., Veltmann, U., Werner, M., Winkelmann, W., Zoubek, A. and Kotz, R.Neoadjuvant therapy for localized osteosarcoma of extremities; results from the Cooperative Osteosarcoma study group COSS of 925 patients in German.;Klin Padiatr,1999
2. Ecklund, K., Laor, T., Goorin, AM., Connolly, LP. and Jaramillo, D. Methothrexate osteopathy in patients with osteosarcoma.;Radiology,1997
3. Gnudi, S., Butturini, L., Ripamonti, C., Avella, M. and Bacci, G. The effects of methotrexate (MTX) on bone: a densitometric study conducted on 59 patients with MTX administered at different doses.;Ital J Orthop Traumatol,1988
4. Bone mineral status during and after therapy of childhood cancer: an increasing population with multiple risk factors for impaired bone health. (Comment on J Bone Miner Res. 2009;14:2002-2009).;Kaste;J Bone Miner Res,1999
5. Outila, TA., Karkkainen, MU. and Lamberg-Allardt, CJ. Vitamin D status affects serum parathyroid hormone concentrations during winter in female adolescents: associations with forearm bone mineral density.;Am J Clin Nutr,2001